Global /United States /Healthcare /Medical Devices /RMD
chevron_leftBack
ResMed Inc. logo

ResMed Inc.

RMD
NYSE: RMD Delayed
211.93USD -2.4%
As of 10 July 2026, ResMed Inc. has a market cap of $30.74B USD, ranking #817 globally and #327 in the United States. It ranks #62 in the Healthcare sector, and #17 in the Medical Devices industry.
Global Rank
817
1d: +1
1w: +6
1m: -
Country Rank
327
1d: 0
1w: +7
1m: -
Sector Rank
62
1d: 0
1w: +1
1m: -
Industry Rank
17
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$30.74BUSD
Enterprise Value
$30.47BUSD
Revenue (TTM)
$5.4BUSD
EBITDA (TTM)
$2.02BUSD
Net Income (TTM)
$1.49BUSD
EBITDA Margin
38%
Profit Margin
28%
PE Ratio
21.5
Forward PE
18.7
PS Ratio
5.7
PB Ratio
5.0
EV/EBITDA
15.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Michael Farrell open_in_new
Employees
9,980
Founded
1989
IPO
02 Jun 1995
Website
resmed.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.4% -4.6% -3.9% -18% -17% -9.5%

News

Loading...

RMD Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
RMD
ResMed Inc
ISIN: US7611521078
Shares Out.:
145.056M1 Shares Float: 143.706M2
TV:
SA:
YF:
RMD
GF:
NQ:
RMD
BA:
RMD
MS:
211.93 USD
London Stock Exchange
MIC: XLON
0KW4
ResMed Inc
ISIN: US7611521078
TV:
SA:
YF:
GF:
BA:
MS:
212.90 USD
OTC Markets
MIC: OTCM
RSMDF
ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ISIN: AU000000RMD6
Shares Out.:
1.464B1 Shares Float: 1.464B2
TV:
SA:
YF:
GF:
BA:
MS:
16.63 USD
Show all 9 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
464%
25.8
$160.73B
423%
56.7
$159.07B
417%
25.6
DHR
$126.55B
312%
34.7
SYK
$120.69B
293%
38.3
$84.93B
176%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
232%
22.2
$96.41B
84.32B EUR
214%
36.7
7741
$60.56B
9.83T JPY
97%
40.0
$44.98B
39.34B EUR
46%
18.7
ALC
$35.94B
28.99B CHF
17%
37.9
$29.98B
203.66B CNY
-2.5%
26.0
chevron_leftBack